BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sandhu A, Tillotson G, Polistico J, Salimnia H, Cranis M, Moshos J, Cullen L, Jabbo L, Diebel L, Chopra T. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020. Emerg Infect Dis 2020;26. [PMID: 32441243 DOI: 10.3201/eid2609.202126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Khanna S, Kraft CS. The interplay of SARS-CoV-2 and Clostridioides difficile infection. Future Microbiol 2021;16:439-43. [PMID: 33847139 DOI: 10.2217/fmb-2020-0275] [Reference Citation Analysis]
2 Lakkasani S, Chan KH, Shaaban HS. Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020. Emerg Infect Dis 2020;26. [PMID: 32620183 DOI: 10.3201/eid2609.202505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Geisen WR, Berger J, Schwartz C, Reddy A, Rai B, Wadih G, Peck J. Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy. IDCases 2020;22:e00962. [PMID: 32983888 DOI: 10.1016/j.idcr.2020.e00962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cimolai N. The Complexity of Co-Infections in the Era of COVID-19. SN Compr Clin Med 2021;:1-13. [PMID: 33937631 DOI: 10.1007/s42399-021-00913-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infect Drug Resist 2021;14:1645-8. [PMID: 33953575 DOI: 10.2147/IDR.S305349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Spigaglia P. COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients. Anaerobe 2020;64:102233. [PMID: 32593567 DOI: 10.1016/j.anaerobe.2020.102233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Ramalingam S, Gunasekaran K, Arora H, Muruganandam M, Padmanabhan P. Clostridium Difficile and Noncirrhotic Hyperammonnemia in a Patient With COVID-19 Infection. Cureus 2021;13:e14533. [PMID: 33880318 DOI: 10.7759/cureus.14533] [Reference Citation Analysis]
8 Páramo-Zunzunegui J, Ortega-Fernández I, Calvo-Espino P, Diego-Hernández C, Ariza-Ibarra I, Otazu-Canals L, Danés-Grases JE, Menchero-Sánchez A. Severe Clostridium difficile colitis as potential late complication associated with COVID-19. Ann R Coll Surg Engl 2020;102:e176-9. [PMID: 32803988 DOI: 10.1308/rcsann.2020.0166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Perisetti A, Goyal H, Gajendran M, Boregowda U, Mann R, Sharma N. Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19. Front Med (Lausanne) 2020;7:588711. [PMID: 33195352 DOI: 10.3389/fmed.2020.588711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
10 Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, Ramos-Martínez A, Muñez-Rubio E, Fernández Carracedo E, Tejada Montes J, Rubio-Rivas M, Arnalich-Fernandez F, Beato Pérez JL, García Bruñén JM, Del Corral Beamonte E, Pesqueira Fontan PM, Carmona MDM, Fernández-Madera Martínez R, González García A, Salazar Mosteiro C, Tuñón de Almeida C, González Moraleja J, Deodati F, Martín Escalante MD, Asensio Tomás ML, Gómez Huelgas R, Casas Rojo JM, Millán Núñez-Cortés J; SEMI-COVID-19 Network. Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One 2021;16:e0251340. [PMID: 33974637 DOI: 10.1371/journal.pone.0251340] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Maslennikov R, Poluektova E, Ivashkin V, Svistunov A. Diarrhoea in adults with coronavirus disease-beyond incidence and mortality: a systematic review and meta-analysis. Infect Dis (Lond) 2021;53:348-60. [PMID: 33583306 DOI: 10.1080/23744235.2021.1885733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, Bentivegna E, Martelletti P, Petrosillo N, Zali MR. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne) 2021;8:775063. [PMID: 34966759 DOI: 10.3389/fmed.2021.775063] [Reference Citation Analysis]
13 Martin E, Philbin M, Hughes G, Bergin C, Talento AF. Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic. J Antimicrob Chemother 2021;76:272-5. [PMID: 33011763 DOI: 10.1093/jac/dkaa400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
14 Granata G, Petrosillo N, Al Moghazi S, Caraffa E, Puro V, Tillotson G, Cataldo MA. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe 2021;:102484. [PMID: 34843959 DOI: 10.1016/j.anaerobe.2021.102484] [Reference Citation Analysis]
15 Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, Ahmad F, Muronetz V, Samy Abousenna M, Zolghadri S, Saboury AA. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021;10:4802. [PMID: 34768321 DOI: 10.3390/jcm10214802] [Reference Citation Analysis]
16 Perisetti A, Gajendran M, Mann R, Elhanafi S, Goyal H. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations. Dis Mon. 2020;66:101064. [PMID: 32807535 DOI: 10.1016/j.disamonth.2020.101064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
17 Morales-Marroquin E, Xie L, Uppuluri M, Almandoz JP, Cruz-Muñoz N, Messiah SE. Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery Patients. J Am Coll Surg 2021;233:223-31. [PMID: 34015452 DOI: 10.1016/j.jamcollsurg.2021.04.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Maslennikov R, Svistunov A, Ivashkin V, Ufimtseva A, Poluektova E, Efremova I, Ulyanin A, Okhlobystin A, Kardasheva S, Kurbatova A, Levshina A, Grigoriadis D, Magomedov S, Dzhakhaya N, Shifrin O, Zharkova M, Yuryeva E, Kokina N, Shirtladze M, Kiseleva O. Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection. Medicine (Baltimore) 2021;100:e27528. [PMID: 34731146 DOI: 10.1097/MD.0000000000027528] [Reference Citation Analysis]
19 Manea E, Jipa R, Milea A, Roman A, Neagu G, Hristea A. Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania. Rom J Intern Med 2021. [PMID: 34053203 DOI: 10.2478/rjim-2021-0020] [Reference Citation Analysis]
20 Ferreira EO, Penna B, Yates EA. Should We Be Worried About Clostridioides difficile During the SARS-CoV2 Pandemic? Front Microbiol 2020;11:581343. [PMID: 33133048 DOI: 10.3389/fmicb.2020.581343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Marinescu AR, Laza R, Musta VF, Cut TG, Dumache R, Tudor A, Porosnicu M, Lazureanu VE, Licker M. Clostridium Difficile and COVID-19: General Data, Ribotype, Clinical Form, Treatment-Our Experience from the Largest Infectious Diseases Hospital in Western Romania. Medicina (Kaunas) 2021;57:1099. [PMID: 34684136 DOI: 10.3390/medicina57101099] [Reference Citation Analysis]
22 Cojocariu C, Girleanu I, Trifan A, Olteanu A, Muzica CM, Huiban L, Chiriac S, Singeap AM, Cuciureanu T, Sfarti C, Stanciu C. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection? World J Clin Cases 2021; 9(33): 10180-10188 [PMID: 34904088 DOI: 10.12998/wjcc.v9.i33.10180] [Reference Citation Analysis]
23 Sheikh AAE, Sheikh AB, Shah I, Khair AH, Javed N, Shekhar R. COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection. Eur J Case Rep Intern Med 2021;8:002771. [PMID: 34527627 DOI: 10.12890/2021_002771] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kullar R, Johnson S, McFarland LV, Goldstein EJC. Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use. Antibiotics (Basel) 2021;10:408. [PMID: 33918619 DOI: 10.3390/antibiotics10040408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Voona S, Abdic H, Montgomery R, Clarkson A, Twitchell H, Hills T, Briggs S, Crooks C, Monaghan TM. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre. Anaerobe 2021;73:102479. [PMID: 34801705 DOI: 10.1016/j.anaerobe.2021.102479] [Reference Citation Analysis]
26 Segala FV, Bavaro DF, Di Gennaro F, Salvati F, Marotta C, Saracino A, Murri R, Fantoni M. Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review. Viruses 2021;13:2110. [PMID: 34834917 DOI: 10.3390/v13112110] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Keating JA, McKinley L, Safdar N. Coronavirus disease 2019 (COVID-19) and antibiotic stewardship: Using a systems engineering approach to maintain patient safety. Infect Control Hosp Epidemiol 2021;42:1416-8. [PMID: 33040756 DOI: 10.1017/ice.2020.1263] [Reference Citation Analysis]
28 Chiu CH, Tsai MC, Cheng HT, Le PH, Kuo CJ, Chiu CT. Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic. J Formos Med Assoc 2021;120:791-3. [PMID: 32713786 DOI: 10.1016/j.jfma.2020.07.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Granata G, Bartoloni A, Codeluppi M, Contadini I, Cristini F, Fantoni M, Ferraresi A, Fornabaio C, Grasselli S, Lagi F, Masucci L, Puoti M, Raimondi A, Taddei E, Trapani FF, Viale P, Johnson S, Petrosillo N, On Behalf Of The CloVid Study Group. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). J Clin Med 2020;9:E3855. [PMID: 33260943 DOI: 10.3390/jcm9123855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
30 Mihaescu A, Augustine AM, Khokhar HT, Zafran M, Masood SSME, Gilca-Blanariu GE, Covic A, Nistor I. Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review. Biomed Res Int 2021;2021:5466656. [PMID: 34557546 DOI: 10.1155/2021/5466656] [Reference Citation Analysis]
31 Rhouma M, Tessier M, Aenishaenslin C, Sanders P, Carabin H. Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance? Antibiotics (Basel) 2021;10:464. [PMID: 33923886 DOI: 10.3390/antibiotics10040464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Bogdanová K, Doubravská L, Vágnerová I, Hricová K, Pudová V, Röderová M, Papajk J, Uvízl R, Langová K, Kolář M. Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia. Life (Basel) 2021;11:1127. [PMID: 34833003 DOI: 10.3390/life11111127] [Reference Citation Analysis]